Fixed dosing of kukoamine B in sepsis patients: Results from population pharmacokinetic modelling and simulation-Reference-Cited by-同舟云学术

Fixed dosing of kukoamine B in sepsis patients: Results from population pharmacokinetic modelling and simulation

Published:2022-04-23 Issue:9 Volume:88 Page:4111-4120
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit J Clinical Pharma

Author:

Wang Huanhuan¹²,Wang Teng¹³,Hu Xiaoyun⁴,Deng Chenhui²,Jiang Ji¹,Qin Hanyu⁴,Dong Kai⁵,Chen Shuai⁵,Jin Chunyan⁵,Zhao Qian¹^ORCID,Du Bin⁴,Hu Pei¹²^ORCID

Affiliation:

1. Clinical Pharmacology Research Center, Beijing Key Laboratory of Clinical PK and PD Investigation for Innovative Drugs, Peking Union Medical College Hospital Union Medical College and Chinese Academy of Medical Sciences Beijing China

2. Clinical Pharmacology Department Beijing Linking Truth Technology Co., Ltd Beiing China

3. Clinical Trial Center, National Medical Products Administration Key Laboratory for Clinical Research and Evaluation of Innovative Drugs, West China Hospital Sichuan University Chengdu Sichuan China

4. Medical ICU, Peking Union Medical College Hospital Union Medical College and Chinese Academy of Medical Sciences Beijing China

5. Clinical Research Center for Innovative Drugs, Tianjin Chase Sun Pharmaceutical Co., Ltd Tianjin China

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.15342

Reference21 articles.

1. Sepsis: definition, epidemiology, and diagnosis

2. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

3. Sepsis: pathophysiology and clinical management

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First-in-Human Safety, Tolerability, and Pharmacokinetics of Single-Dose Kukoamine B Mesylate in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Phase I Study;Infectious Diseases and Therapy;2024-01-30

2. Population pharmacokinetics of nalbuphine in patients undergoing general anesthesia surgery;Frontiers in Pharmacology;2023-03-21